Bloomberg Intelligence cover image

Novo Falls by Record After Wegovy Maker Slashes Forecast, Names New CEO

Bloomberg Intelligence

00:00

Intro

This chapter explores the decline in stock value of a major pharmaceutical company following revised profit forecasts and leadership changes. It also examines the implications for the healthcare market and investor sentiment in response to these developments.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app